Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05217108 · ClinicalTrials.gov registry record · NA
A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
A NA study of Healthy Lifestyle and Lifestyle, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05217108: Recruiting NA study of Healthy Lifestyle and Lifestyle, sponsored by M.D. Anderson Cancer Center.
NCT05217108 is a NA study of Healthy Lifestyle and Lifestyle that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants, below the 223-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05217108, a NA study of Healthy Lifestyle and Lifestyle, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.
Conditions Studied
Interventions
- DEVICE FitBit
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-01-05 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT05217108 shows while recruiting
NCT05217108 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 223-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (10% lower).
The record links to 2 conditions, with Healthy Lifestyle appearing as the primary indexed condition, and to 1 intervention - of which FitBit is the first listed.
NCT05217108 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05217108 about?
NCT05217108 is a clinical study titled "A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study". To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.
What is the current status of trial NCT05217108?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-01-05. Estimated completion is 2026-10-31.
What conditions does trial NCT05217108 study?
This clinical trial studies the following conditions: Healthy Lifestyle, Lifestyle.
What interventions are being tested in trial NCT05217108?
The interventions under investigation include: FitBit (DEVICE).
Who is sponsoring clinical trial NCT05217108?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05217108 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Lifestyle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05217108's enrollment target sits among peer trials
200 4th of 16 higher than 13 of 16 other Healthy Lifestyle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Lifestyle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Neurophysiological Markers of Brain Health
RECRUITING · NA
-
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
RECRUITING · NA
-
Families Implementing Good Health Traditions for Life
RECRUITING · NA
-
Personalized Health Self-Management Training for Colorectal Cancer Survivors
RECRUITING · NA
-
Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men
ACTIVE NOT RECRUITING · NA
-
BATokines as Biomarkers of Brown Fat in Humans
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI